
Management Change6 Aug 2026, 02:47 pm
Sarda Proteins Director Resigns; Approves ₹100 Cr Rights Issue
AI Summary
Sarda Proteins Limited announced the resignation of non-executive director Mr. Gunvantray Jayantilal Zaladi, effective August 5, 2026, due to personal reasons. The Board of Directors also approved a Rights Issue of equity shares not exceeding ₹10,000 lakhs (₹100 Crore). A Rights Issue Committee has been formed to oversee the process, and necessary intermediaries have been appointed. The company will separately announce the record date for the issue.
Key Highlights
- Director Gunvantray Jayantilal Zaladi resigns from Sarda Proteins.
- Company approves a Rights Issue of up to ₹100 Crore.
- A Rights Issue Committee has been constituted.
- Intermediaries for the rights issue have been appointed.
Price Impact
More from SRDAPRT